Canada’s public drug plans should not pay for a new medication that slows cognitive decline in patients with Alzheimer’s disease because it’s not clear the expensive therapy provides clinically ...
A group of Indigenous elders and chiefs is suing to void all forestry permits on a vast territory in northern Quebec, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results